Intervention Review

Ibuprofen for Alzheimer's disease

  1. Naji Tabet1,*,
  2. Howard Feldman2

Editorial Group: Cochrane Dementia and Cognitive Improvement Group

Published Online: 22 APR 2003

Assessed as up-to-date: 5 MAY 2008

DOI: 10.1002/14651858.CD004031

How to Cite

Tabet N, Feldman H. Ibuprofen for Alzheimer's disease. Cochrane Database of Systematic Reviews 2003, Issue 2. Art. No.: CD004031. DOI: 10.1002/14651858.CD004031.

Author Information

  1. 1

    University of Brighton, Postgraduate Medical School, Brighton, UK

  2. 2

    Vancouver Hospital and Health Sciences Center, UBC Division of Neurology, Vancouver, British Columbia, Canada

*Naji Tabet, Postgraduate Medical School, University of Brighton, Falmer, Brighton, BN1 9PH, UK.

Publication History

  1. Publication Status: Stable (no update expected for reasons given in 'What's new')
  2. Published Online: 22 APR 2003


Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions and you will be able to log in to access content. Some users may also log in directly via OpenAthens.

Please note that there are currently a number of duplicate entries in the list of institutions. We are actively working on fixing this issue and apologize for any inconvenience caused.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.